Zhende Medical Co Ltd (603301) — Capital Reinvestment Ratio
Latest as of September 2025:
1.07x
Zhende Medical Co Ltd (603301) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥101.93 Million) in capital expenditures (CN¥109.24 Million). See Zhende Medical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.07x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥101.93 Million
CNY
Capital Expenditures
CN¥109.24 Million
CNY
Data as of
Sep 2025
Most recent filing
Zhende Medical Co Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks Zhende Medical Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Zhende Medical Co Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for Zhende Medical Co Ltd from 2014 to 2025. For live market cap and broader valuation context, see Zhende Medical Co Ltd (603301) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.02x | CN¥538.49 Million | CN¥550.22 Million | ▼ -38.8% |
| 2024 | 1.67x | CN¥461.14 Million | CN¥769.69 Million | ▲ +25.9% |
| 2023 | 1.33x | CN¥452.11 Million | CN¥599.24 Million | ▲ +119.0% |
| 2022 | 0.61x | CN¥1.25 Billion | CN¥754.12 Million | ▼ -28.8% |
| 2021 | 0.85x | CN¥817.63 Million | CN¥695.47 Million | ▲ +142.9% |
| 2020 | 0.35x | CN¥3.12 Billion | CN¥1.09 Billion | ▼ -74.7% |
| 2019 | 1.38x | CN¥197.76 Million | CN¥273.79 Million | ▼ -87.6% |
| 2018 | 11.20x | CN¥20.25 Million | CN¥226.70 Million | ▲ +1313.5% |
| 2017 | 0.79x | CN¥182.34 Million | CN¥144.45 Million | ▼ -31.1% |
| 2016 | 1.15x | CN¥138.57 Million | CN¥159.23 Million | ▲ +608.9% |
| 2015 | 0.16x | CN¥142.70 Million | CN¥23.13 Million | ▼ -76.6% |
| 2014 | 0.69x | CN¥83.63 Million | CN¥57.93 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow